QuicksortRX Expands Charleston, South Carolina, Operations
11/16/2023
The new 4,000-square-foot corporate headquarters will be located at 2 Cumberland Street. Operations are scheduled to begin in December 2023.
“Charleston is an amazing city to live and work in. I’m lucky to call this my hometown, and we couldn’t ask for a better place to grow a company. It also helps that talented people want to move here,” said QuicksortRx Co-Founder and CEO Jonathan Yantis.
QuicksortRx helps health systems streamline pharmaceutical market analysis to reduce the cost of quality healthcare. The platform unifies purchase, cost, and compliance information to simplify supply chain management and ensure hospitals secure medications at the best price.
“QuicksortRx’s decision to expand its headquarters in Charleston County acknowledges the Lowcountry’s top destination reputation. We are pleased that a successful South Carolina experience prompted economic growth and the desire to stay in the community where it began,” Secretary of Commerce Harry M. Lightsey III noted.
Project Announcements
Poland-Based JGB Brothers Plans Bamberg County, South Carolina, Production Operations
01/23/2026
Electric Research and Manufacturing Cooperative Plans Waddell, Arizona, Transformer Production Operations
01/23/2026
Viking Attachments Expands Morgan City, Louisiana, Manufacturing Operations
01/23/2026
France-Based Reju Plans Rochester, New York, Textile Regeneration Operations
01/23/2026
Heil Trailer International Expands Athens, Tennessee, Manufacturing Operations
01/23/2026
Ampirical Expands Covington, Louisiana, Operations
01/23/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
The New Industrial Revolution in Biotech
Q4 2025